Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-08-13 10:47:12 UTC |
---|
Updated at | 2021-06-29 00:47:52 UTC |
---|
NP-MRD ID | NP0000622 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 5-Methoxytryptamine |
---|
Description | 5-Methoxytryptamine, also known as mexamine or 5-MT, belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. It is biosynthesized via the deacetylation of melatonin in the pineal gland. 5-MT acts as a full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors. 5-Methoxytryptamine exists in all living organisms, ranging from bacteria to humans. Its affinity for the 5-HT5A receptor is unknown. It has no affinity for the 5-HT3 receptor and is affinity for the 5-HT1E receptor is very weak in comparison to the other 5-HT1 receptors. 5-MT has been shown to occur naturally in the body in low levels. |
---|
Structure | InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 |
---|
Synonyms | Value | Source |
---|
2-(5-Methoxyindol-3-yl)ethylamine | ChEBI | 3-(2-Aminoethyl)-5-methoxyindole | ChEBI | 5-MeOT | ChEBI | 5-Methoxy-1H-indole-3-ethanamine | ChEBI | 5-Mot | ChEBI | 5-MT | ChEBI | 5MOT | ChEBI | Mexamine | ChEBI | O-Methylserotonin | ChEBI | 2-(5-Methoxy-1H-indol-3-yl)ethanamine | HMDB | Lopac-m-6628 | HMDB | Meksamin | HMDB | Methoxytryptamine | HMDB | Mexamine base | HMDB | Meksamine | HMDB | 5 Methoxytryptamine | HMDB | 5-Methoxytryptamine | ChEBI |
|
---|
Chemical Formula | C11H14N2O |
---|
Average Mass | 190.2417 Da |
---|
Monoisotopic Mass | 190.11061 Da |
---|
IUPAC Name | 2-(5-methoxy-1H-indol-3-yl)ethan-1-amine |
---|
Traditional Name | 5 methoxytryptamine |
---|
CAS Registry Number | 608-07-1 |
---|
SMILES | COC1=CC2=C(NC=C2CCN)C=C1 |
---|
InChI Identifier | InChI=1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 |
---|
InChI Key | JTEJPPKMYBDEMY-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Tryptamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Anisole
- 2-arylethylamine
- Alkyl aryl ether
- Aralkylamine
- Substituted pyrrole
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Ether
- Azacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 121.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Geffard M, Dulluc J, Rock AM: Antisera against the indolealkylamines: tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-methoxytryptophan, and 5-methoxytryptamine tested by an enzyme-linked immunosorbent assay method. J Neurochem. 1985 Apr;44(4):1221-8. [PubMed:3919158 ]
- Rom-Bugolavskaia ES, Shcherbakova VS, Komarova IV: [The effect of melatonin and mexamine on the human thyroid under in-vitro conditions]. Eksp Klin Farmakol. 1997 Jul-Aug;60(4):46-9. [PubMed:9376758 ]
- Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, Roots I, Brockmoller J: Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Pharmacogenet Genomics. 2005 Aug;15(8):579-87. [PubMed:16007002 ]
- Romsing S, Bokman F, Bergqvist Y: Determination of melatonin in saliva using automated solid-phase extraction, high-performance liquid chromatography and fluorescence detection. Scand J Clin Lab Invest. 2006;66(3):181-90. [PubMed:16714247 ]
|
---|